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Reduction in muscle strength with aging is due to both loss of muscle mass (quantity) and intrinsic force production (quality).
Along with decreased functional capacity of the muscle, age-related muscle loss is associated with corresponding comorbidities
and healthcare costs. Mitochondrial dysfunction and increased oxidative stress are the central driving forces for age-related
skeletal muscle abnormalities. The increased oxidative stress in the aged muscle can lead to altered excitation-contraction
coupling and calcium homeostasis. Furthermore, apoptosis-mediated ﬁber loss, atrophy of the remaining ﬁbers, dysfunction of
the satellite cells (muscle stem cells), and concomitant impaired muscle regeneration are also the consequences of increased
oxidative stress, leading to a decrease in muscle mass, strength, and function of the aged muscle. Here we summarize the
possible eﬀects of oxidative stress in the aged muscle and the beneﬁts of physical activity and antioxidant therapy.
1. Introduction
With improved life quality conditions and the availability of
treatments, life expectancy and consequently the number of
elderly in the population have increased [1]. This change in
population composition places increasing emphasis on the
treatment of chronic, noncommunicable diseases as they
have become major causes of death and disability worldwide,
thus driving the need to understand the mechanism of aging
and ﬁnd treatments for age-related diseases [2].
The skeletal muscle is the largest organ in the body com-
prising ~40% of its mass. It plays fundamental roles in move-
ment, posture, and energy metabolism. The loss of skeletal
muscle mass and function with age can have a major impact
on quality of life and results in increased dependence and
frailty. Age-related decline of skeletal muscle function (sarco-
penia) results in strength loss [3]. This loss stems from two
major sources, reductions in muscle mass (i.e., quantity)
and decrease in its intrinsic capacity for producing force
(i.e., quality). Both can be the consequence of several factors
(Figure 1), including oxidative stress that is the result of the
accumulation of reactive oxygen and nitrogen species
(ROS/RNS). The free-radical theory of aging was established
more than 60 years ago [4] and has become one of the most
studied theories to have been proposed. It is now accepted
that this theory and its various spin-oﬀs cannot alone explain
the aging process [5, 6]. Nevertheless, huge amounts of data
indicate that ROS-mediated aging phenotypes and age-
related disorders exist [7, 8].
During physiological homeostasis the overall oxidative
balance is maintained by the production of ROS/RNS from
several sources and their removal by antioxidant systems,
including endogenous or exogenous antioxidant molecules.
At physiological concentrations ROS/RNS play essential
roles in a variety of signaling pathways. There is an optimal
level of ROS/RNS to sustain both cellular homeostasis and
adaptive responses, and both too low and too high levels of
ROS/RNS are detrimental to cell functions [9]. The skeletal
muscle consumes large quantities of oxygen and can generate
great amounts of ROS and also reactive nitrogen species.
Mitochondria are one of the most important sources of
ROS in the skeletal muscle; furthermore, NADPH oxidase
(NOX) [10], xanthine oxidase [11], and phospholipase A2
(PLA2) [12, 13] are also involved in ROS production.
The origin of the increased ROS production and oxida-
tive damage is mitochondrial dysfunction with aging [14],
caused by age-related mitochondrial DNA mutations,
deletions, and damage [15], as well as the impaired ability
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of muscle cells to remove dysfunctional mitochondria [16].
Oxidative phosphorylation impairment can lead to decreased
ATP production and further generation of ROS [4]. Interest-
ingly, aging is associated not only with an increase in oxida-
tive damage but also with an upregulation of antioxidant
enzymes in the skeletal muscle [9]. Furthermore, the iron
content of the mitochondria in the skeletal muscle increases
with aging, amplifying the oxidative damage with the gener-
ation of ROS [17]. Increased ROS production, mitochondrial
DNA damage, and mitochondrial dysfunction was observed
in aged muscles [18–20].
The skeletal muscle is highly plastic and shows sev-
eral adaptations towards mechanical and metabolic stress
[21, 22]. Oxidative stressors, like ROS, have long been taken
into account as harmful species with negative eﬀects in the
skeletal muscle [23]. Proteins such as biomolecules are fre-
quently aﬀected by oxidation; thus, elevated ROS levels can
cause reversible or irreversible posttranslational modiﬁcation
of cysteine, selenocysteine, histidine, and methionine. Oxida-
tive posttranslational modiﬁcations of proteins are character-
istic in the aged muscle, such as carbonylation which alters
protein function [24]. The oxidative capacity of muscles is
strongly associated with health and overall well-being.
Enhanced oxidative capacity in the skeletal muscle protects
against several pathological phenomena (insulin resistance,
metabolic dysregulation,muscle losswith aging, and increased
energetic deﬁcits in myopathies) [25, 26]. These protective
eﬀects are largely associated with enhanced mitochondrial
function and elevated numbers of mitochondria, which
can protect against cellular stress.
Given the rapidly aging population, it is essential to better
understand the development, progression, prevention, and
treatment of age-related muscle diseases. The aim of this
review is to discuss the possible eﬀects of age-related oxida-
tion on the skeletal muscle and highlight the beneﬁts of phys-
ical activity and intake of antioxidant compounds to protect
from oxidative stress.
2. Oxidative Stress and EC-Coupling
Machinery in Aging
Ca2+, as a second messenger, is necessary for muscle con-
traction. Ca2+ can originate from the extracellular space
(the heart and smooth muscle) and from the intracellular
store of the sarcoplasmic reticulum (SR) (in the skeletal mus-
cle exclusively from SR). Excitation-contraction (EC) cou-
pling, the steps from the trigger action potential to the
development of force, starts with the activation of the voltage
sensor dihydropyridine-sensitive, L-type Ca2+ channels
(DHPRs). These can open the Ca2+ release channel ryano-
dine receptor (RyR) of SR [27]. The released Ca2+ freely
diﬀuses into the intracellular space and, after binding with
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Figure 1: Schematic summary of the eﬀects of oxidative stress in the aged skeletal muscle. The age-related increase in oxidative stress can
result in mitochondrial dysfunction, and the dysfunctional mitochondria can further generate reactive oxygen species. The increased
oxidative stress can lead to a decrease both in muscle quality and in muscle quantity. As a consequence of the increased oxidative stress,
excitation-contraction uncoupling, altered calcium homeostasis, apoptosis-mediated ﬁber loss, atrophy of the remaining ﬁbers,
dysfunction of the satellite cells (muscle stem cells), and impaired muscle regeneration can be observed in the aged muscle leading to a
decrease in muscle mass, strength, and function.
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troponin-C (TnC), initiates muscle contraction. During
relaxation, the Ca2+ is taken up by the sarco/endoplasmic
reticulum calcium pump (SERCA) into the SR [28]. If any
step in the EC-coupling pathway is disrupted, the voltage-
induced Ca2+ release from SR will be deﬁcient and less cyto-
plasmic Ca2+ will be available to bind with TnC (Figure 2).
EC coupling has a unique structure in muscle ﬁbers,
called calcium release units (CRUs). They are formed by
two membrane systems: the transverse- (t-) tubule, where
the trigger action potential (depolarization) from the sarco-
lemma goes into the ﬁber, and the calcium store SR terminal
cisternae [29]. In a fully developed skeletal muscle ﬁber, a
central t-tubule usually forms junctions with two SR forming
a triad. The voltage sensor DHPRs localized in the t-tubule
membrane [30] are in direct connection with the closely
apposed calcium release channel RyRs in the SR membrane.
2.1. RyR. Mammalian RyR has three isoforms, which were
originally identiﬁed in the skeletal muscle (RyR1), in the
heart muscle (RyR2), and in the brain (RyR3). It is now
known that some tissues express all three mammalian RyR
isoforms [31–33]. Several cellular compounds (e.g., ATP,
HCl, Ca2+, and Mg2+), speciﬁc proteins (phosphatases and
kinases), and endogenous oxidative species can regulate
RyR functions [34]. Abramson and Salama [35] were the ﬁrst
to propose a redox-dependent gating model of RyR, in which
the channel pore opens after the oxidation and closes after
the reduction of critical sulfhydryl moieties within the RyR
complex. Gating transitions of the RyR channel are extremely
fast; the open state usually lasts no longer than a few millisec-
onds; thus, this hypothesis has been called into question
because of its slow kinetic [36]. Additionally, isolated RyR1
reconstituted in an artiﬁcial lipid bilayer functioned similarly
independently of the presence of cofactors to maintain the
catalytic transfer of electrons [37].
Another possibility to control RyR1 gating is the trans-
membrane redox potential of SR. In healthy mammalian
cells, the redox potential of the cytosol is approximately
-230mV [38]. The majority of redox buﬀers within the cyto-
sol of a muscle cell are based on the relative concentration of
oxidized (GSSG) and reduced (GSH) glutathione or NADH
and NAD+. In diﬀerent nonmuscle cells, GSSG and GSH
transporters have been found across the ER membrane
[38, 39]. These transporters play an essential role in estab-
lishing and maintaining the membrane redox potential
gradient. It was shown that glutathione transport across
SR/ER membranes is very fast and correlates with the
expression of RyR1 in terminal cisternae [40]. These ﬁnd-
ings imply the presence of one or more transmembrane
redox sensors in the RyR1 channel.
To study the redox regulation of RyR1 channel activity,
Feng et al. [41] used artiﬁcial lipid bilayer membranes and
precisely controlled the redox state by adjusting the
[GSSG]/[GSH] ratio to change redox potentials on both the
lumenal and cytoplasmic sides of the reconstituted channel.
Redox sensing may represent a widespread mechanism by
which RyR1 channels respond to local changes in transmem-
brane redox potential. As mentioned above, disulﬁde bond
formation (sulfhydryl oxidation) in RyR1 usually takes place
in the oxidizing environment of the SR lumen, not in the
reducing environment of the cytosol.
Pessah et al. [42] demonstrated that RyR1 channel gating
was accompanied by changes in the microenvironment of
hyperreactive Cys residues. It was assumed that the localized
redox potential could inﬂuence the domain with the redox
sensor, which might change the stability of the closed state.
This means that the closed but not the open conformation
of RyR1 senses redox changes. In this framework, the rapid
gating transitions of RyR1 would not coincide with oxidation
and reduction of disulﬁde bonds, and local changes in the
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Figure 2: Possible actions of age-related oxidative stress reducing skeletal muscle contraction. Accumulation of reactive oxygen and nitrogen
species in the aged muscle results in protein modiﬁcation and/or damage that could reduce muscle quality by altering muscle ﬁber activation
at the neuromuscular junction (NMJ), excitation-contraction (EC) coupling (DHPR, RyR, SERCA, calsequestrin), and cross-bridge cycling
within the myoﬁbrillar apparatus. DHPR: dihydropyridine receptor; FKBP: FK506 binding protein; RyR: ryanodine receptor; SERCA:
sarco/endoplasmic reticulum Ca2+ pump; TnC: troponin-C.
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redox environment would inﬂuence the overall operation of
the channel.
With advancing age, RyR becomes increasingly oxidized
and nitrosylated, which leads to leaky release channels.
RyR1 from aged mice was shown to be more oxidized and
cysteine-nitrosylated compared to that from young animals.
Furthermore, these RyR channels lacked the stabilizing sub-
unit FKBP12. Treating aged mice with the small molecule
rycal drug S107 stabilized binding of FKBP12 to RyR1 reduc-
ing intracellular Ca2+ leakage, enhancing Ca2+ release from
SR, decreasing ROS, and improving muscle exercise [43].
Similarly, increased Ca2+ leakage from the SR, primarily
through the RyRs, was found in type I ﬁbers of aged humans,
and a reducing treatment with dithiothreitol inhibited RyR
Ca2+ leakage, thus increasing net SR Ca2+ accumulation
[44]. Other evidence of partially defective SR in the aged
muscle is the decreased frequency of spontaneous Ca2+
release (spark) through RyR, observed by Park et al. [45]
and the authors of this review (unpublished data).
The expression of RyR also changes with age. Unpub-
lished data of the authors of this review showed reduced
RyR expression in aging mice. The whole tetramer was
almost completely absent in the EDL muscle of old animals,
and only a smaller amount of degraded RyR was found.
Interestingly, this was not the case in mice that did voluntary
exercise throughout their entire life.
2.2. RyR-Associated Proteins. A lot of studies have inves-
tigated the redox dependence of accessory proteins of
RyR1, which contribute to the tight regulation of channel
activity in the mammalian skeletal muscle. These proteins
include the voltage sensor skeletal dihydropyridine recep-
tor (L-type Ca2+ channel), calmodulin, triadin, junctin,
FKBP12 (12 kDa FK506 binding protein), and calsequestrin
in the SR lumen [34, 46].
To date there is no evidence that triadin and junctin
have any role in the redox regulation of RyR1. On the
other hand, reactive sulfhydryl groups within RyR1 chan-
nels have been shown to help the binding of calmodulin,
and functional responses of calmodulin to RyR1 may be
redox regulated [47]. It was proposed that probably more
than one class of sulfhydryl residues within the RyR1
channel complex suﬀer chemical modiﬁcation, each con-
tributing to a speciﬁc function. This question is still open
because of the structural complexity of RyR1 and its asso-
ciated proteins.
Calsequestrin-1 is a high-capacity Ca2+ buﬀer, localized
in the lumen of SR in close proximity to RyR1. It has been
demonstrated that nNOS and NOX2 also colocalize with
RyRs at the triad junctions, and the latter generate ROS,
which stimulate Ca2+ release from the SR through RyR1
[48]. Recently, it was hypothesized that in muscle ﬁbers lack-
ing Calsequestrin-1, the close positioning of either nNOS or
NOX2 to RyR1 and the Ca2+-dependent activation of nNOS
could be the consequence of increased production of ROS
and RNS. This could ﬁnally lead to nitrosylation and glu-
tathionylation of speciﬁc cysteine residues causing oxidative
modiﬁcations that further increase the probability of leaky
RyR1 channels [49].
RyR1 has four subunits to bind the small FK506 protein
(FKBP12) [50]. FKBP12 associates mainly with the skeletal
muscle isoform to regulate RyR1 function. Pharmacological
removal of FKBPs causes uncoupling of RyR1 ion channels
from their neighbors and thus activates Ca2+ release from
SR [51]. A recent study shows that the 1,4 benzoderivative
S107 binds to multiple RyR1 sites with low aﬃnity and stabi-
lizes the RyR1-FKBP12 complex depending on the redox
state of the calcium channel [52].
2.3. DHPR. DHPR is located in the t-tubules and plays a role
in EC coupling as the voltage sensor triggering Ca2+ release
from the SR after an action potential. More than 20 years
ago, Delbono et al. [53] recorded a signiﬁcant reduction of
maximum charge movement and L-type calcium current in
muscle ﬁbers from biopsies of 65-75-year-old patients. This
was accompanied with decreased Ca2+ release from the SR.
Just a few years later it was shown that ROS may also target
DHPRs, since ROS alter the dynamics of muscle K+ contrac-
tures [54]. A later study by the same research group using the
mammalian diaphragm demonstrated an increase in tension
after antioxidant application that is clearly dependent on
DHPR function [55]. These results support the hypothesis
that the DHPR redox state and RyR function are modulated
in an interactive manner and modify contractility.
It was also shown that the expression of the α1 subunit of
DHPR decreases with age and this is associated with the loss
of skeletal muscle strength [56]. These ﬁndings were ampli-
ﬁed by the fact that DHPR expression levels can be regulated
by diﬀerent mechanisms, independently from gene tran-
scription or mRNA expression. In a very recent study, a novel
ﬁnding was reported that cytoplasmic-located fast skeletal
muscle troponin T3 (TnT3) regulates DHPR expression in
skeletal muscle ﬁbers and calpain-induced cleavage of TnT3
is associated with DHPR downregulation in aged mice [57].
The reduced DHPR expression with aging increases the
number of uncoupled RyR1s and, thus, decreases SR Ca2+
release which leads to EC uncoupling and ﬁnally decreased
force production.
2.4. SERCA. The sarco/endoplasmic reticulum Ca-ATPase
(SERCA) is the calcium pump that uptakes Ca2+ from the
cytosol to the SR during muscle relaxation. It has an impor-
tant role in maintaining the resting intracellular Ca2+ con-
centration (around 100nM). Evidence for NO inhibition
of the Ca-ATPase was observed in the rabbit skeletal muscle,
where sustained contractions led to signiﬁcant (40–50%)
inactivation of the pump [58]. One possible explanation could
be the reactions with critical SH groups, since peroxynitrite
treatment of Ca-ATPase from the rabbit skeletal muscle was
correlated with oxidative and nitrosativemodiﬁcations of cys-
teines at several positions, of which one was deemed responsi-
ble for enzyme inhibition [59]. Recently it was shown that
SERCA1 is reversibly regulated via NO-dependent S-
glutathiolation of speciﬁc cysteine residues which are embed-
ded within the transmembrane domains of the pump. Some
speciﬁc amino acid peroxides react selectively with a subset
of cysteine residues of SERCA1, representing one of the
targets for NO-dependent S-glutathiolation [60]. In a
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parallel study it was also demonstrated that antioxidant treat-
ment aﬀects intracellular Ca2+ concentration, increasing the
maximum rates of ATP hydrolysis and uptake of Ca2+ by
SERCA in the diaphragm [61].
The 53 kDa isoform of sarcalumenin, the major luminal
glycoprotein associated with SERCA, was found to be down-
regulated in the aged human muscle [62]. Interestingly this
was accompanied with the upregulation of Calsequestrin-1.
In a recent study on humans, it was shown that these changes
were reversed after 9 weeks of training by electrical stimula-
tion [63] of the vastus lateralis muscle of sedentary senior
volunteers. The decreased active SERCA, and thus insuﬃ-
cient SR Ca2+ content, can also be explained by the ﬁndings
of Boncompagni et al. [64]. Their electron microscopic study
proved the presence of SERCA and Calsequestrin-1-rich
tubular aggregates in the aging mouse skeletal muscle. They
hypothesized that polymerization of SERCA induces its
inactivity and this decreases the Ca2+ uptake capacity of
SR. Similarly, the accumulated inactive Calsequestrin-1 in
tubular aggregates is missing from SR and leads to reduced
Ca2+ storage capacity.
3. The Effects of Age-Dependent Structural
Changes in the Skeletal Muscle
It has been suggested by Renganathan and colleagues [56]
that an uncoupling between DHPR and RyR1 in the CRUs
(insuﬃcient transmission of the sarcolemmal depolarization
to the calcium release channel) with aging is one of the major
determinants of the progressive decline in muscle strength.
This has been supported by transmission EM studies [65],
which show a progressive disarrangement of triads in the
aging human skeletal muscle. This results in a drastic reduc-
tion in the overall number of CRUs available for releasing
Ca2+ to initiate the sliding of contractile ﬁlaments and gener-
ate force. Notwithstanding that the total number of CRUs is
decreased, on average by more than 50% in the aging muscle,
the decrease in the total amount of both DHPR and RyR1
was less, because the decrease in the total number of
SR/t-tubule junctions is accompanied by an increase in the
average size of RyR clusters which compensate for the loss
of triads.
Besides Ca2+, ATP is also necessary to generate force, as
well as for relaxation in the skeletal muscle. The main source
of ATP is mitochondria. It was shown that mitochondria and
CRUs are functionally linked to each other via ROS- and
Ca2+-mediated cross-talk [66]. Furthermore, these two
organelles are structurally connected by tethers, which pro-
mote proximity and suﬃcient calcium signaling [67]. In the
aged muscle, not only the ultrastructure, density, and dispo-
sition of mitochondria and CRUs but also their reciprocal
associations are altered. The density of CRUs and mitochon-
dria is decreased in the aged muscle, with an increased num-
ber of damaged mitochondria and mitochondria misplaced
from their normal triadic position. A signiﬁcant reduction
in CRU-mitochondria pair density and their tethering was
also observed in aged mice. These changes were accompanied
with increased oxidative stress and with decreased mitochon-
drial Ca2+ uptake and SR Ca2+ release [68]. These wrong
direction changes in the skeletal muscle can be prevented
by regular exercise. The number of mitochondria is higher
in athletic than in sedentary seniors, and furthermore, the
number of CRU-mitochondria pairs is three times higher in
senior sportsmen than in sedentary individuals. Since the
correct association between CRUs and mitochondria is nec-
essary for eﬃcient ATP production, this can explain the sig-
niﬁcantly superior muscle performance in lifelong exercising
seniors [68]. Similar results were obtained with mice that had
access to running wheels for the second part of their lives
(from 1 to 2 years of age) [69]. The authors of these studies
concluded in their results that the huge age-dependent
decrease aﬀecting EC-coupling apparatuses and mitochon-
drial functions in the skeletal muscle of humans and mice
can be partly associated with inactivity in old age.
4. Oxidative Stress and Satellite Cell
Dysfunction with Aging
The skeletal muscle has the remarkable ability to regenerate
in response to injury. This regenerative capacity is due to
the muscle stem cells (MuSCs), also called satellite cells that
reside between the muscle ﬁber and its surrounding basal
lamina [70]. The satellite cells are mitotically and physiolog-
ically in a quiescent state (a G0 reversible arrest state) in the
healthy muscle and express the Pax7 transcription factor.
They are stimulated upon muscle injury to enter the cell cycle
and proliferate extensively and form myoblasts that will sub-
sequently diﬀerentiate and fuse to form muscle ﬁbers. The
diﬀerentiated myocytes are capable of fusing together and,
with the preexisting myoﬁbers, restore the muscle tissue. A
small subset of the expanding satellite cells does not commit
to terminal diﬀerentiation but self-renews to restore the qui-
escent satellite cell pool for further needs [71]. The regenera-
tive function of satellite cells declines with age [72, 73]
(Figure 3). At advanced geriatric age, this decline is maximal
owing to transition from a normal quiescence into an irre-
versible senescence (a G0 irreversible arrest).
The age-related deﬁcits in muscle regeneration have been
linked to changes in the satellite cell environment (such as
inﬂammatory status) and/or satellite cell-intrinsic mecha-
nisms [74]. Both the number and the functionality of satellite
cells decrease with age [75–79], switching from quiescence to
a senescent state [76]. The satellite cells are unequally distrib-
uted among the diﬀerent ﬁber types and diﬀer between mus-
cles. In the rat extensor digitorum longus (EDL) muscle,
satellite cells are observed most frequently on type IIA ﬁbers
and at approximately equal frequencies on type IIB and type I
ﬁbers [80]. Interestingly, the soleus contains a considerably
higher percentage of satellite cells than the EDL [80]. In the
young adults, satellite cell content did not diﬀer between type
I and type II muscle ﬁbers [81]. Aging is associated with a
switch from fast to slow ﬁber type [82]. The abundance of
resident satellite cells declines with age in myoﬁbers from
both fast- and slow-twitch muscles in mice [83], and a
decrease in FGF signaling as a possible limiting factor of sat-
ellite cell function during muscle aging has been identiﬁed
[83]. In contrast, satellite cell content is reported to be specif-
ically reduced in type II skeletal muscle ﬁbers in the elderly,
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but not in type I ﬁbers [84]. This decline in satellite cell con-
tent might be an important factor in the etiology of type II
muscle ﬁber atrophy, which accompanies the loss of skeletal
muscle with age [81, 84].
The function of satellite cells is altered by oxidative stress
with aging. In the aged muscle, the satellite cells exhibit a
reduced capacity to proliferate and self-renew. The decrease
in the self-renewing muscle stem cell pool can lead to
decreased regenerative capacity of the muscle. The quiescent
satellite cells have a low metabolic rate and display only a few
active mitochondria and therefore are exposed to low levels
of oxidative stress [85]. Gene expression studies have also
indicated diﬀerences in the transcriptional proﬁle of aged
versus young satellite cells, e.g., changes in genes associated
with mitochondrial function [86]. The ROS production was
higher in isolated satellite cells from the aged muscle [87].
Furthermore, a decline in antioxidant capacity in satellite
cells was also observed with age, diminishing satellite cell
function with increased ROS levels [88]. It was reported that
the antioxidant activity of catalase and glutathione transferase
is reduced in aged satellite cells [89]. Several redox-dependent
signaling pathways are deregulated in aged satellite cells;
decreased Notch [90], increased Wnt (wingless/integrated)
[91], increased p38/MAPK (mitogen-activated protein
kinase) [77], and JAK-STAT3 (Janus kinase-signal transducer
of activation) [92] signaling were observed.
Mitochondrial dysfunction can result from decreased
NAD+ (nicotinamide adenine dinucleotide) levels of the cells.
Stem cells are thought to rely predominantly on glycolysis to
yield energy, decreasing NAD+ concentration [93]. The
reduction of the cellular NAD+ level and its eﬀect on mito-
chondrial activity was shown to be a pivotal switch to modu-
late satellite cell senescence [78]. Treatment with the NAD+
precursor, nicotinamide riboside, induced the mitochondrial
unfolded protein response and synthesis of prohibitin pro-
teins, rejuvenated the muscle stem cells in aged mice, and
enhanced life span [78].
The activities of the ubiquitin-proteasome system,
autophagy, and chaperones appear to decline with age [94].
During myogenesis and regeneration, an increase in protein
synthesis and removal of misfolded proteins can be observed
[73]. Oxidative stress can inﬂuence muscle satellite cells by
altering their protein homeostasis. Basal autophagy is essen-
tial to maintain the stem cell quiescent state [95]. Autophagy
was shown to be essential to maintain the stemness of sat-
ellite cells by preventing the senescence caused by mito-
chondrial dysfunction and oxidative stress associated with
aging [95].
5. Age-Related Muscle Loss and Oxidative Stress
Sarcopenia, the age-associated generalized and progressive
reduction in muscle mass, increases the susceptibility to mus-
cle injury, serious falls, obesity, and diabetes [96], predicting
frailty, disability, poor quality of life, and mortality in the
elderly [97–101]. The prevalence of low muscle mass is esti-
mated between 8 and 40% depending on the population stud-
ied and the methods used to identify sarcopenia; it ranges
from 15% at 65 years to 50% at 80 years [100, 101]. Progres-
sive muscle loss starts at approximately the age of 40 years; it
is estimated at about 8% per decade until the age of 70 years
and then it increases to 15% per decade [102]. Reduction in
muscle mass is usually combined with an increase in body
fat mass; the accumulation of fat can be observed within
the muscle ﬁbers. The high levels of ROS in the aging muscle
can induce the transition of satellite cells into an adipogenic
phenotype. This muscle-to-fat transition can explain the
increased intramuscular adipose tissue associated with
sarcopenia [103, 104].
Age-related muscle atrophy was shown to be associated
with a decrease in the total number of muscle ﬁbers and a
simultaneous decrease in the size of the individual ﬁbers. It
was reported that age-related muscle loss in rodents [105]
and humans [82] can occur due to the loss of muscle ﬁbers
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Figure 3: Age-related alterations in satellite cells. Mitochondrial dysfunction and decreased antioxidant capacity of aged satellite cells can lead
to increased oxidative stress. The satellite cell dysfunction results in decreased regenerative capacity of the muscle. As a consequence of
increased oxidative stress, a decrease in autophagy can lead to senescence.
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and a decrease in the cross-sectional area of the remaining
ﬁbers. Several factors were reported to contribute to muscle
atrophy with aging. The role of reduced protein synthesis,
declines in neural function, hormonal deﬁcits, chronic low-
grade inﬂammation, loss of mitochondrial function, nuclear
apoptosis, reduced function of satellite cells, and oxidative
stress was reported [96, 106].
A relationship was observed between oxidative stress and
muscle mass [107–110]. The disruption of signaling path-
ways involving skeletal muscle reactive oxygen species has
received increasing attention [6]. Age-associated accumula-
tion of nitrotyrosine in muscle proteins was reported [108].
The accumulation of mitochondrial and nuclear DNA
damage leads to the loss of skeletal muscle ﬁbers [111].
Mitochondria-mediated apoptosis represents a central pro-
cess driving age-related muscle loss [112]. Mitochondrial
dysfunction is related not only to the loss of its capacity to
generate ATP but also to the activation of apoptotic pathways
leading to the irreversible cell loss that is characteristic of
sarcopenia [112].
Further studies have shown that ROS accumulation can
increase proteolysis leading to loss of muscle mass; increased
ROS production activates the ubiquitin-proteasome path-
way. Aging is associated with greater proteasome content
and activity [113], increased expression of the ubiquitin
ligase MuRF1 (Muscle RING-ﬁnger protein-1) and atrogin-1
[114], and increased calpain activity [115]; however, further
studies are required to explore the role of oxidative stress
in these age-related alterations. The potential role of age-
dependent mitochondrial dysfunction and cumulative oxi-
dative stress as the underlying cause of age-associated ﬁber
atrophy remains controversial; the pharmacological attenu-
ation of age-related mitochondrial redox changes failed to
rescue the age-associated muscle ﬁber atrophy, implying
that the muscle mitochondrial redox environment is not
a key regulator of ﬁber atrophy during sarcopenia [3].
Recently it was reported that sedentary humans display
an age-related decline in the mitochondrial protein optic
atrophy 1 (OPA1) that is associated with muscle loss [116].
FoxOs (Forkhead box proteins) are master regulators of
autophagy and the ubiquitin-proteasome system [117] and
are activated by oxidative stress and Akt inhibition. Impor-
tantly, the acute inhibition of OPA1 results in an increased
oxidative stress, and in vivo inhibition of FoxOs was suﬃ-
cient to reduce muscle atrophy in Opa1−/− mice [117].
6. Antioxidant Therapies and Effects of Exercise
on the Aged Muscle
The eﬀects of exercise on aging in the skeletal muscle are very
controversial. There is widespread agreement that oxidation
could increase during exercise. Early studies have suggested
that ROS play important roles in the inﬂammatory response
to high-intensity or long-lasting exercise [118]. On the other
hand, it has also long been known that moderate exercise
increases the antioxidant capacity of the skeletal muscle by
mitochondrial remodeling [119]. A more recent study sug-
gested that endurance training stimulates mitochondrial
remodeling which leads to an increase in mitochondrial
content and function [120]. Unfortunately recent rodent
models suggest that exercise-induced mitochondrial remod-
eling is defective in the aged muscle [121]. In contrast, as
mentioned above, moderate exercise can improve the num-
ber of CRU-mitochondria pairs and thus provide more
ATP and Ca2+ for contraction [68]. Furthermore,
resistance-type exercise training represents an eﬀective strat-
egy to increase satellite cell content and reverse type II muscle
ﬁber atrophy in humans [81].
Another target of exercise against oxidative stress is the
increased activity of enzymatic antioxidants (i.e., glutathione
peroxidase, catalase, and superoxide dismutase) accompany-
ing the exercise-induced ROS generation. For example,
skeletal muscle-speciﬁc manganese superoxide dismutase-
deﬁcient mice, which showed reduced exercise activity
without atrophy, presented signiﬁcantly improved exercise
activity of the skeletal muscle after a single administration
of an antioxidant [122].
Numerous investigations have aimed to explore the
eﬀects of antioxidant treatment on skeletal muscle perfor-
mance. Some of them also studied old muscles and found
positive eﬀects of such a treatment. For example, hydroxytyr-
osol, which has high free-radical-scavenging capabilities,
caused increased in vivo force in aged rats [123]. Recent stud-
ies showed positive eﬀects of resveratrol [124], some plant
extracts (Rhus coriaria [125] and Rosmarinus oﬃcinalis
[126]), and vitamins (vitamin C [127]). The increasing
number of similar studies nowadays shows the importance
and topicality of ﬁnding good antioxidant treatment for
the aged muscle.
As discussed above, several studies report an elevation in
levels of oxidized protein and DNA in the older skeletal mus-
cle. To date, RyR is the only key protein in EC coupling for
which lifelong voluntary training was investigated and found
to improve its expression level in aged mice (unpublished
data of the authors). The data showed a beneﬁcial antioxi-
dant eﬀect of selenium supplementation on skeletal muscle
performance in old animals. However, as the authors could
not prove the direct eﬀects of antioxidant treatment on
ROS production, there are several key proteins in EC cou-
pling which could be positively altered and, thus, enhance
force production.
The eﬀect of antioxidant compounds on aged satellite
cells has already been reported. Tocotrienol is a vitamin E
analogue bearing high antioxidant activity. The tocotrienol-
rich fraction (TRF) replenished the regenerative capacity of
the human senescent satellite cells [128]; furthermore, TRF
is able to ameliorate antioxidant defence mechanisms and
improve replicative senescence-associated oxidative stress
in human satellite cells [129]. The vitamin E analogue trolox
treatment prevented the appearance of senescence markers,
restored the expansion, and rescued the proliferative and
regenerative defect of geriatric satellite cells [72]. The eﬀect
of resveratrol was studied in the mouse myoblast cell and
showed protection against ROS by improving Sirt1 (Sirtuin1)
levels, increasing antioxidant production, and reducing apo-
ptotic signaling and cell death [130]. Interestingly, the eﬀect
of exercise on the oxidative stress of satellite cells has not
yet been investigated in the literature. The protective eﬀects
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of exercise, resveratrol, and their combination was shown to
increase muscle mass in rats, probably associated with antia-
poptotic signaling pathways through activation of AMPK
(AMP-activated protein kinase)/Sirt1 [131]. In contrast,
administration of the long-term mitochondria-targeted
antioxidant, mitoquinone mesylate, failed to attenuate age-
related oxidative damage or rescue the loss of muscle mass
and function in the skeletal muscle of old mice [132].
7. Concluding Remarks
Lifelong maintenance of muscle mass and strength is a global
health challenge. With an aging population, the problem of
sarcopenia is becoming more and more important, and eﬀec-
tive strategies are required to improve muscle performance.
An average 30-year-old will lose about 25% of his or her mus-
cle strength by age 70 and 50% of it by age 80. The improve-
ment of mobility and independence is key for old people, and
it relieves society from healthcare and social support costs.
Our knowledge about the signaling pathways mediating
age-related muscle loss is still limited. Oxidative stress and
subsequent alterations in signaling pathways could lead to
diﬀerent pathophysiological events at diﬀerent stages of life,
especially in old age. As was shown in this review, a lot of tar-
gets in skeletal muscle could be altered by increased oxidative
stress with aging. Some of them are targets of intrinsic fac-
tors, but there are some which depend mainly on extrinsic
actions. The eﬀects of oxidative stress in muscles are so
diverse that improving only one step is usually not enough
to get better muscle performance. This means that only com-
bined therapy could be eﬀective, and continuous training will
also allow muscle ﬁbers to incorporate higher levels of exog-
enous antioxidants from dietary supplements.
In conclusion, the risks of oxidative stress-induced dam-
age can be minimized with regular exercise, which has bene-
ﬁcial eﬀects on physical and mental health. We have to
emphasize that while it is never too late to begin exercise,
an early start and regular practice throughout life would
greatly improve outcomes in later years and slow down a
body’s aging process. A lot of people try to start a training
program late in life, when muscle performance is already
diminished. It follows that muscle research has to promote
the development of a new generation of physically active,
healthy elderly citizens. To achieve this, and to minimize oxi-
dative stress, the key could be a carefully developed exercise
protocol combined with adequate antioxidant supplemen-
tation. However, exercise can be restricted due to orthope-
dic or cardiopulmonary limitations, which highlights the
importance of the exploration of antioxidant therapy or
nontraditional exercise. Regular exercise to maintain mus-
cle function also has beneﬁcial eﬀects by reducing oxida-
tive stress, not only in the muscle, but in all tissue, a
fact that intrinsically would reduce/delay aging.
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